Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

A new review published in Genes & Diseases highlights the transformative role of microRNAs (miRNAs) in regulating and potentially reversing adipose tissue fibrosis, a condition closely linked to ...

BOSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced positive ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology. One of the key reasons lies in the disease's unique fibrotic ...